Home / Stock ratings / CLS
Stock rating
Celestica, Inc. (CLS) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Celestica, Inc. 67 out of 100 (Favorable). Its highest factor score is catalyst setup at 100, and its lowest is risk-adjusted profile at 45.
MELANY ratingRated 2026-10-13CLS · composite score
Why CLS scores 67/100
CLS's 8 factor scores run from 45 to 100, and 3 of them sit above its composite of 67. Here is how CLS breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 18.2x, earnings growth accelerating
- PEG ratio 1.00 (< 1 = undervalued)
Margins, returns on capital, and balance-sheet strength.
- ROE 53%
Direction and relative strength of the recent share-price trend.
- Price +6.7% above 50-day MA
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +6%
- Earnings in 13 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Analyst targets 33% upside
Near-term events that could move the stock.
- Earnings in 13 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for CLS
- Performance partly driven by Technology sector, rotation away from this theme would hurt
Sector and theme context
Celestica, Inc. sits in the Technology sector theme, which MELANY currently rates 91/100 for strength. Theme strength feeds CLS's momentum and catalyst factors above.
CLS trade plan (Pro)
MELANY has a full position plan for Celestica, Inc.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates CLS
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Celestica, Inc.'s 67/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about CLS
Is Celestica, Inc. (CLS) a buy?
As of 2026-10-13, MELANY rated Celestica, Inc. Favorable with a composite score of 67/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Celestica, Inc.'s MELANY score?
Celestica, Inc. (CLS) has a MELANY composite score of 67/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the CLS stock rating calculated?
MELANY scores CLS from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Celestica, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Celestica, Inc. (CLS) Favorable with a composite of 67/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the CLS stock price forecast?
MELANY does not publish price targets or forecasts for CLS. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 67/100 across eight factors for Celestica, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is CLS stock overvalued or undervalued?
MELANY's valuation factor currently reads 49/100 for Celestica, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives CLS's read.
What price should I buy CLS at?
Rather than chasing the current price, MELANY computes a smart entry zone for CLS: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying CLS stock?
The top risks MELANY currently flags for Celestica, Inc.: Performance partly driven by Technology sector, rotation away from this theme would hurt. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Celestica, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 58/100 for Celestica, Inc., and earnings track record, at 80/100. The 67/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will CLS stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 62/100 for CLS right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this CLS rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores CLS continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, CLS included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.